<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M693</article-id>
      <article-id pub-id-type="publisher-id">molbank-2010-M693</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>4,6-Diamino-5-(3,4-dichlorobenzylidene)pyrimidin-2(5<italic>H</italic>)-one</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lobo</surname>
            <given-names>Gricela</given-names>
          </name>
          <xref rid="af1-molbank-2010-M693" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2010-M693" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Charris</surname>
            <given-names>Jaime</given-names>
          </name>
          <xref rid="af1-molbank-2010-M693" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Charris</surname>
            <given-names>Katiuska</given-names>
          </name>
          <xref rid="af1-molbank-2010-M693" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Romero</surname>
            <given-names>Jes&#xFA;s</given-names>
          </name>
          <xref rid="af1-molbank-2010-M693" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Taddei</surname>
            <given-names>Antonieta</given-names>
          </name>
          <xref rid="af2-molbank-2010-M693" ref-type="aff">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2010-M693"><label>1</label>Laboratorio de S&#xED;ntesis Org&#xE1;nica, Facultad de Farmacia, Universidad Central de Venezuela, Caracas 1051, Venezuela; E-Mails: <email>jaime.charris@ucv.ve</email> (J.C.); <email>katiukca.charris@gmail.com</email> (K.C.); <email>ucvromeroj@gmail.com</email> (J.R.)</aff>
      <aff id="af2-molbank-2010-M693"><label>2</label>Departamento de Biolog&#xED;a Celular, Universidad Sim&#xF3;n Bol&#xED;var, Caracas 1080, Venezuela; E-Mail: <email>ataddei@usb.ve</email></aff>
      <author-notes>
        <corresp id="c1-molbank-2010-M693"><label>*</label> Author to whom correspondence should be addressed; E-Mails: <email>gricelalobo@gmail.com</email> or <email>gricela.lobo@ucv.ve</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>09</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>09</month>
        <year>2010</year>
      </pub-date>
      <volume>2010</volume>
      <issue>3</issue>
      <elocation-id>M693</elocation-id>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>07</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>08</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A new compound, 4,6-diamino-5-(3,4-dichlorobenzylidene)pyrimidin-2(5<italic>H</italic>)-one, was synthesized and its IR, <sup>1</sup>H NMR,<sup>13</sup>C NMR, MS spectroscopic data and elemental analysis are presented.</p>
      </abstract>
      <kwd-group>
        <kwd>pyrimidine</kwd>
        <kwd>urea</kwd>
        <kwd>antimicrobial activity</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>There is continuous interest in the synthesis of pyrimidine derivatives because of the diverse biological properties associated with these systems. For instance, compounds with annulated uracils have antitumor [<xref ref-type="bibr" rid="B1-molbank-2010-M693">1</xref>], antibacterial [<xref ref-type="bibr" rid="B2-molbank-2010-M693">2</xref>], leishmanicidal [<xref ref-type="bibr" rid="B3-molbank-2010-M693">3</xref>] anticonvulsant [<xref ref-type="bibr" rid="B4-molbank-2010-M693">4</xref>], antirubella [<xref ref-type="bibr" rid="B5-molbank-2010-M693">5</xref>], anti-HIV [<xref ref-type="bibr" rid="B6-molbank-2010-M693">6</xref>], calcium channel modulation [<xref ref-type="bibr" rid="B7-molbank-2010-M693">7</xref>], and selective hepatitis B virus inhibition [<xref ref-type="bibr" rid="B8-molbank-2010-M693">8</xref>] activity.</p>
      <p>The Biginelli reaction is a well-known multicomponent reaction which involves a one-pot cyclocondensation of an aldehyde, a methylene-active compound and urea/thiourea, has been used in the synthesis of pyrimidine derivatives [<xref ref-type="bibr" rid="B9-molbank-2010-M693">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2010-M693">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2010-M693">11</xref>,<xref ref-type="bibr" rid="B12-molbank-2010-M693">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2010-M693">13</xref>]. Nevertheless, little attention has been given thus far to the synthesis and biological activity of the pyrimidine nucleus with the benzylidene group in position 5, next to two amino groups in positions 4 and 6. In continuation of our work [<xref ref-type="bibr" rid="B11-molbank-2010-M693">11</xref>,<xref ref-type="bibr" rid="B12-molbank-2010-M693">12</xref>], in this communication, the synthesis, characterization and antibacterial activity of 4,6-diamino-5-(3,4- dichlorobenzylidene)-2(5<italic>H</italic>)-pyrimidinone <bold>2</bold> are presented. Compound <bold>2</bold> was obtained from the reaction between (3,4-dichlorobenzylidene)propanedinitrile <bold>1</bold> and urea. The title compound thus synthesized is original to this study. The reaction of <bold>1</bold> and urea have not been previously studied.</p>
	  <p><disp-formula><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M693-i001.tif"/></disp-formula></p>
      <p>A mixture of (3,4-dichloroenzylidene)propanedinitrile <bold>1</bold> [<xref ref-type="bibr" rid="B14-molbank-2010-M693">14</xref>] (0.2 g, 1.19 mmol), urea (0.14 g, 2.33 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.20 g, 1.17 mmol) in methanol was refluxed for 24 h. The solid obtained was filtered and washed with water. After recrystallization from water-DMF, <bold>2</bold> was obtained as a yellowish solid (0.18 g, 80%). Synthesis of other pyrimidine derivatives and studies of their biological activities are in progress, including tests of antibacterial and anticonvulsive activity as a part of a research program directed to the synthesis of novel heterocyclic compounds of pharmacological interest.</p>
      <p>Melting point: 133&#x2013;135 &#xB0;C</p>
      <p>IR (KBr, cm<sup>&#x2212;1</sup>): 3270 (NH), 1780 (C=O), 1651 (C=N)</p>
      <p><sup>1</sup>H NMR (DMSO-<italic>d</italic><sub>6</sub>, 270 MHz): &#x3B4;: 8.04 (<sup>1</sup>H, s, olefinic-H); 7.97 (1H, d, <italic>J</italic> = 8.4 Hz, Ar-H); 7.76 (<sup>1</sup>H, d, <italic>J</italic> = 2.2 Hz, Ar-H); 7.56 (1H, dd, <italic>J</italic> = 10.8 and 2.0 Hz, Ar-H); 5.22 (4H, s, NH<sub>2</sub>).</p>
      <p><sup>13</sup>C NMR (DMSO-<italic>d</italic><sub>6</sub>, 69 MHz): 166.27, 164.89, 135.20, 131.56, 131.47, 131.03, 124.00, 116.46, 116.24, 115.94.</p>
      <p>EI-MS <italic>m/z</italic> (rel. int. %): 285 (5) [M+2]<sup>+</sup>; 284 (9) [M+1]<sup>+</sup>; 283 (27) [M]<sup>+</sup>; 255 (100) [M -CO]<sup>+</sup>; 184 (63), 77 (27).</p>
      <p>Anal. Calcd for C<sub>11</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>4</sub>O: C: 46.67%; H: 2.85%; Cl: 25.05%; N: 19.79%; O: 5.65%. Found: C: 46.31%; H: 2.69%; N: 19.74%.</p>
    <sec>
      <title>Antibacterial Activity</title>
      <p>Compound <bold>2</bold> showed antibacterial activity against <italic>Bacillus cereus</italic> (ATCC 14579) (Gram positive bacteria) and <italic>Staphylococcus aureus</italic> (ATCC 25922) (Gram positive bacteria), as reference drugs were used: Ampicillin, Sulbactam, Norfloxacin and Nystatin.</p>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2010-M693">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2010-M693-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M693-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2010-M693-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M693-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2010-M693-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M693-s002.pdf">
   <label>Supplementary File 3</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We are grateful to &#x201C;Consejo de Desarrollo Cient&#xED;fico y Human&#xED;stico de la Universidad Central de Venezuela /CDCH-UCV)&#x201D; for financing the Project: <bold>PI 06-00-6759-2007</bold>.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2010-M693">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grivsky</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Siyal</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Duch</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Nichol</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimetoxibencil)-5-methylpyrido [2,3-d]Pyrimidine</article-title>
          <source>J. Med. Chem.</source>
          <year>1980</year>
          <volume>23</volume>
          <fpage>237</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00177a025</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2010-M693">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gossnitzer</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Feierl</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, structure investigations, and antimicrobial activity of selected s-<italic>tran</italic>-6-aril-4-isopropyl-2-2[2-[(E)-1-phenylalkylidene]-(E)-hydrazino]-1,4-dihydropyrimidine hydrochlorides</article-title>
          <source>Eur. J. Pharm. Sci.</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>49</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1016/S0928-0987(01)00202-0</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2010-M693">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ram</surname>
              <given-names>V.J.</given-names>
            </name>
			<name>
              <surname>Haque</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of functionalized pyrazolo[3,4-<italic>d</italic>]pyrimidine as potential leishmanicides</article-title>
          <source>Indian J. Chem.</source>
          <year>1995</year>
          <volume>34B</volume>
          <fpage>521</fpage>
          <lpage>524</lpage>
        </citation>
      </ref>
      <ref id="B4-molbank-2010-M693">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calis</surname>
              <given-names>U.</given-names>
            </name>
			<name>
              <surname>Koksal</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and evaluation of anticonvulsant activities of some new aryl-hexahydropyrimidine-2,4-dione</article-title>
          <source>Arzneim.-Forsch/Drug Res.</source>
          <year>2001</year>
          <volume>51</volume>
          <fpage>523</fpage>
          <lpage>528</lpage>
        </citation>
      </ref>
      <ref id="B5-molbank-2010-M693">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saladino</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Ciambecchini</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Maga</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Mastromarino</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Conti</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Botta</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A new and efficient synthesis of substituted 6-[(2&#x2019;-dialkylamino)ethyl]pyrimidine and 4-N,N-dialkyl-6-vinylcytosine derivatives and evaluation of their anti-Rubella activity</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2002</year>
          <volume>10</volume>
          <fpage>2143</fpage>
          <lpage>2153</lpage>
          <pub-id pub-id-type="doi">10.1016/S0968-0896(02)00077-9</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2010-M693">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>San-Felix</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Velazquez</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Perez-Perez</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Balzarini</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>De Clercq</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Canarasa</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Novel series of TSAO-T derivatives. Synthesis and anti-HIV-1 activity of 4-, 5-. and 6- substituted pyrimidine analogues</article-title>
          <source>J. Med. Chem.</source>
          <year>1994</year>
          <volume>37</volume>
          <fpage>453</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00030a004</pub-id>
          <pub-id pub-id-type="pmid">7509877</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2010-M693">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanden Eynde</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Audiart</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Canonne</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Michel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>van Haverbeke</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kappe</surname>
              <given-names>C.O.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Aromatization of Dihydropyrimidines Structurally Related to Calcium Channel Modulators of the Nifedipine-Type</article-title>
          <source>Heterocycles</source>
          <year>1997</year>
          <volume>45</volume>
          <fpage>1967</fpage>
          <lpage>1978</lpage>
        </citation>
      </ref>
      <ref id="B8-molbank-2010-M693">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nath</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tyrrell</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Design and synthesis of novel 5-substituted acyclic pyrimidine nucleosides as potent and selective inhibitor of hepatitis B virus</article-title>
          <source>J. Med. Chem.</source>
          <year>2002</year>
          <volume>45</volume>
          <fpage>2032</fpage>
          <lpage>2040</lpage>
          <pub-id pub-id-type="doi">10.1021/jm010410d</pub-id>
          <pub-id pub-id-type="pmid">11985471</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2010-M693">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Catalysis of the Biginelli Reaction by Ferric and Nickel Chloride Hexahydrates. One-Pot Synthesis of 3,4-Dihydropyrimidin-2(1<italic>H</italic>)-ones</article-title>
          <source>Synthesis</source>
          <year>2002</year>
          <fpage>466</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2002-20956</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2010-M693">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hazarkhani</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Karimi</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-Bromosuccinimide as an Almost Neutral Catalyst for Efficient Synthesis of Dihydropyrimidinones Under Microwave Irradiation</article-title>
          <source>Synthesis</source>
          <year>2004</year>
          <fpage>1239</fpage>
          <lpage>1242</lpage>
        </citation>
      </ref>
      <ref id="B11-molbank-2010-M693">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lobo</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Charris</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Valderrama</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Taddei</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>4,6-Diamino-5-[4-(dimethylamino)&#xAD;benzyl&#xAD;idene]&#xAD;pyrimidin-2(5H)-one</article-title>
          <source>Molbank</source>
          <year>2009</year>
          <volume>2009</volume>
          <fpage>M615</fpage>
          <pub-id pub-id-type="doi">10.3390/M615</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2010-M693">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lobo</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Charris</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Valderrama</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Castelli</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Taddei</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>4,6-Diamino-5-(4-methyl&#xAD;benzylidene]pyrimidin-2(5H)-one</article-title>
          <source>Molbank</source>
          <year>2010</year>
          <volume>2010</volume>
          <fpage>M653</fpage>
          <pub-id pub-id-type="doi">10.3390/M653</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2010-M693">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aydin</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of 4-[4-(dimethylamino)phenyl)]-5-acethyl-6-phenyl-3,4-dihydropyrimidin-2-(1<italic>H</italic>)thione</article-title>
          <source>Molbank</source>
          <year>2006</year>
          <volume>2006</volume>
          <fpage>M468</fpage>
          <pub-id pub-id-type="doi">10.3390/M468</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2010-M693">
        <label>14.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Tietze</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Beifus</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Trost</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Fleming</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Heathcock</surname>
              <given-names>C.H.</given-names>
            </name>
          </person-group>
          <source>Comprehensive Organic Synthesis</source>
          <publisher-name>Pergamon Press</publisher-name>
          <publisher-loc>Oxford, UK</publisher-loc>
          <year>1991</year>
          <volume>Volume 2</volume>
		  <comment>Chapter 1.11</comment>
		  <fpage>341</fpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
